Accessing treatments for MS
The MS Society believes that people with MS should have access to proven treatments for their condition no matter where they live in the UK. However, not everyone with MS gets access to the right treatment at the right time, and in some cases people with MS are denied access altogether.
Are you having problems accessing Sativex?
Sativex is a cannabis-based medicine that is administered in the form of a mouth spray. Although Sativex has been licensed for the treatment of spasticity in people with MS in the UK, it has not been assessed by the National Institute for Health and Clinical Excellence (NICE). As a result, decisions about whether to provide the drug have to be made locally by the NHS. Whilst there are fewer policies supporting your entitlement to MS drugs not approved by NICE, you can still (and should) make a case for access to this treatment.If you are having problems accessing Sativex, read the following information guide, which includes a simple step-by-step guide on action you can take.
Access to Sativex
![[doc]](/display_images/document_icons/doc.gif){kind=icon}
MS Society Tysabri campaign
The MS Society launched a campaign in 2008 on acess to Tysabri (natalizumab) when we discovered that eligible people were not able to access the treatment. Penny and Ruth have been campaigning for access to Tysabri in Wakefield with the support of the Pins and Needles Group. Read their story.Prescription charges campaign
The MS Society is part of the Prescription Charges Campaign, which brings together 23 charities calling on the government to abolish unfair prescription charges for people with all long-term conditions.Since April 2009, people with cancer no longer have to pay for prescriptions. This is wonderful news, but many more people in need are still waiting. There is plenty of evidence that many people with long-term conditions currently struggle to afford their prescriptions, and often choose not to fill prescriptions because of the cost.
Read more about the campaign.
